GHK-Cu
Naturally occurring copper tripeptide (Gly‑His‑Lys‑Cu) studied for skin regeneration, wound healing, hair support and broad gene‑expression effects.
Explore calculators for this peptide
Use the Peptide Research Tools to experiment with reconstitution-style scenarios, mg/kg ranges and simplified half-life curves for GHK-Cu. All values are placeholders and must be aligned with your own research protocol.
Open GHK-Cu in calculators →
Research focus & potential applications
GHK‑Cu is an endogenous copper‑binding tripeptide found in plasma and wound fluid, widely studied for its ability to modulate gene expression, stimulate repair processes and support skin and hair health.
Work across cell, animal and cosmetic‑oriented human studies links GHK‑Cu to collagen and glycosaminoglycan synthesis, improved wound healing quality, anti‑inflammatory signalling and favourable shifts in many aging‑related pathways.
Research areas & putative benefits
How GHK‑Cu is being explored in skin, hair and systems‑biology contexts.
- Support of skin regeneration, including increased collagen, elastin and glycosaminoglycan production, improved firmness and texture in cosmetic studies.
- Enhanced wound healing quality, with better organization of collagen fibres, reduced scar formation and faster re‑epithelialization in preclinical models.
- Positive effects on hair parameters such as hair density, follicle size and scalp health markers in topical formulations.
- Broad gene‑expression modulation toward reduced inflammation, oxidative stress and fibrosis, and improved tissue remodelling and DNA repair signatures.
Mechanism stack
Key pathways through which GHK‑Cu appears to drive repair and rejuvenation signals.
Extracellular matrix
Collagen, elastin & GAGs
GHK‑Cu stimulates fibroblasts to increase synthesis of collagen types I and III, elastin and glycosaminoglycans such as dermatan and chondroitin sulphate, supporting dermal matrix renewal and tensile strength.
Gene signalling
Repair‑oriented transcriptome shift
Transcriptomic analyses indicate GHK‑Cu can up‑regulate genes linked to DNA repair, antioxidant defences and stem‑cell support, while down‑regulating many associated with inflammation, tissue destruction and cancer‑promoting processes.
Inflammation & oxidation
Anti‑inflammatory & antioxidant
GHK‑Cu reduces pro‑inflammatory cytokines and lipid peroxidation in various models and boosts antioxidant enzymes, contributing to a micro‑environment more conducive to controlled regeneration rather than chronic inflammation.
Hair & microcirculation
Follicle signalling & vascular support
On the scalp, GHK‑Cu supports dermal papilla cell activity, extracellular matrix health and microcirculation around follicles, which together are associated with improved hair shaft quality and retention in cosmetic settings.
Evidence snapshot
Representative findings from skin, wound and hair‑focused GHK‑Cu studies.
| Model / context | Observation | Notes |
|---|---|---|
|
Dermal fibroblast cultures
Cellular (skin)
|
GHK‑Cu increased fibroblast proliferation and collagen, elastin and glycosaminoglycan synthesis, while improving cell viability under stress conditions. | Provides mechanistic support for its use in anti‑aging and wound‑healing formulations. |
|
Wound healing models
Preclinical wound
|
Topical or injected GHK‑Cu improved wound closure rates, collagen fibre organization and reduced scar formation compared with controls in animal models. | Suggests both faster and higher‑quality tissue repair rather than simple speed increases alone. |
|
Human cosmetic skin studies
Cosmetic clinical
|
GHK‑Cu‑containing creams and serums have shown improvements in skin firmness, elasticity, fine wrinkles and photodamage scores over weeks to months versus baseline or comparator products. | These are cosmetic‑grade, not drug‑grade, trials but align with mechanistic expectations for skin rejuvenation. |
|
Hair & scalp formulations
Cosmetic hair
|
Copper peptide blends including GHK‑Cu have been associated with increased hair fullness, reduced shedding and improved scalp condition in cosmetic use, particularly when combined with other supportive actives. | Helps differentiate GHK‑Cu as more skin‑and‑hair broad versus AHK‑Cu’s more hair‑centric profile. |
Risk frame & unknowns
Considerations and open questions around GHK‑Cu use.
Important research caveats
- Most human evidence comes from cosmetic‑grade studies; rigorous randomized trials for hard clinical endpoints are limited.
- Topical use at cosmetic concentrations appears well tolerated, but long‑term systemic exposure data are sparse.
- Formulation details (pH, vehicle, additional actives) strongly influence bioavailability and outcomes, complicating comparison between products.
- Copper homeostasis is tightly regulated; extreme or poorly controlled exposure to copper complexes could pose theoretical risks in susceptible individuals.
This dossier summarizes mechanistic, preclinical and cosmetic‑oriented clinical findings on GHK‑Cu for scientific and educational purposes only.
It does not provide medical advice, treatment guidance or dosing recommendations.